Artivion | CRY - 净收入

股票价格

37.04

每天变化

-0.82 -2.17%

每月一次

-6.49%

每年

53.18%

Q1 预测

35.91

金融业

USD

USD 857.66M

现金及等价物

USD 73.43M

USD 34.77M

USD 337.5M

USD 85.84M

USD 311.12M

股息收益率

0

USD 1.14M

USD 6.87M

1.5K

EPS每股收益

USD -0.05

股本和储备

USD 438.69M

USD 61.01M

债务利息支出

USD 7.83M

USD -0.05

USD 214.87M

USD 1.56B

USD -2.29M

USD 56.62M

USD 4.39M

普通股股本

USD 424K

942.13

USD -1.27M

USD 95.78M

销售和管理费用

USD 50.02M

USD 90.55M

贸易债权人

USD 16.5M

应收帐款人

USD 134.06M

	净收入	更改		日
Abbott	USD 1.78B		132M	2025-12
Accuray	USD 2.54M		6.49M	2024-12
AngioDynamics	USD -4.41M		6.33M	2025-02
Artivion	USD -2.29M		167K	2024-09
AtriCure	USD 1.76M		2.02M	2025-12
Baxter International	USD -1.13B		1.08B	2025-12
Becton, Dickinson and Co.	USD 382M		111M	2025-12
Boston Scientific	USD 672M		83M	2025-12
Edwards Lifesciences	USD 91.2M		199.9M	2025-12
Inogen	USD -5.96M		373K	2024-09
Integra LifeSciences	USD -1.7M		3.7M	2025-12
J&J	USD 5.12B		36M	2025-12
Mesa Laboratories	USD -1.68M		5.1M	2024-12
Orthofix International	USD -126M		98.61M	2024-12
Pfizer	USD -1.65B		5.19B	2025-12
ResMed	USD 392.59M		44.06M	2025-12
Stryker	USD 849M		10M	2025-12
Surmodics	USD -11.54M		3.99M	2024-09
Tandem Diabetes Care	USD -589K		20.58M	2025-12
Teleflex	USD -714.33M		305.44M	2025-12
Terumo	JPY 32.65B		2.4B	2025-12
Trinity Biotech	USD -5.14M		11.82M	2025-09